Description: Investors say the FDA’s approval process of medical devices is inefficient and opaque. The maker of a non-invasive device that’s proven to identify melanomas risks it all to tell the tale.
Questions for discussion:
- What does this report have to say about the affect the FDA approval process has had on the financing of innovative developments?
- Â Is the trend likely to change?
- How should investors deal with this trend?